[{"Assets_0_Q3_USD":661513000.0,"CommonStockSharesOutstanding_0_Q3_shares":77085715.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-188439000.0,"NetIncomeLoss_1_Q3_USD":-87743000.0,"NetIncomeLoss_3_Q3_USD":-232704000.0,"StockholdersEquity_0_Q3_USD":291407000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":77066000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":76819000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":77066000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":76819000.0,"Ticker":"INSM","CIK":"1104506","name":"INSMED INC","OfficialName":"Insmed Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2980602494.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181030"}]